A tissue sealant based on reactive multifunctional polyethylene glycol.

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Surgical Innovation

Background:

• Developing effective synthetic tissue sealants is crucial for improving surgical outcomes.
• Existing sealants may have limitations in gelling speed, adhesion, or biocompatibility.

Purpose of the Study:

• To develop and evaluate a rapidly gelling synthetic tissue sealant based on polyethylene glycol (PEG).
• To assess the sealant's adhesion, pressure resistance, hemostatic efficacy, and biocompatibility in vitro and in vivo.

Main Methods:

• Synthesis of tetra-succinimidyl and tetra-thiol-derivatized PEG.
• Application of the sealant using a sprayer/mixer device.
• In vitro adhesion tests on collagen membranes, PTFE grafts, and carotid arteries.
• In vitro burst pressure tests on various defect types.
• In vivo hemostasis and biocompatibility studies in rabbit arteries and subcutaneous implants.

Main Results:

• The PEG-based sealant demonstrated rapid gelling and strong adhesion to various tissues and grafts.
• Achieved high burst pressures, significantly exceeding capillary blood pressure and relevant hypertensive levels.
• In vivo studies showed immediate hemostasis, reduced blood loss, and good tissue compatibility.
• Sealant performance was directly linked to the presence of active succinimidyl ester and thiol groups.

Conclusions:

• The developed synthetic PEG sealant offers rapid gelling, excellent adhesion, and robust sealing capabilities.
• The sealant is effective in achieving hemostasis and is biocompatible with biological tissues.
• Quality control methods like HPLC are valuable for ensuring batch consistency and performance.